Literature DB >> 12650591

The consequences of translational and rotational entropy lost by small molecules on binding to proteins.

Christopher W Murray1, Marcel L Verdonk.   

Abstract

When a small molecule binds to a protein, it loses a significant amount of rigid body translational and rotational entropy. Estimates of the associated energy barrier vary widely in the literature yet accurate estimates are important in the interpretation of results from fragment-based drug discovery techniques. This paper describes an analysis that allows the estimation of the rigid body entropy barrier from the increase in binding affinities that results when two fragments of known affinity and known binding mode are joined together. The paper reviews the relatively rare number of examples where good quality data is available. From the analysis of this data, we estimate that the barrier to binding, due to the loss of rigid-body entropy, is 15-20 kJ/mol, i.e. around 3 orders of magnitude in affinity at 298 K. This large barrier explains why it is comparatively rare to observe multiple fragments binding to non-overlapping adjacent sites in enzymes. The barrier is also consistent with medicinal chemistry experience where small changes in the critical binding regions of ligands are often poorly tolerated by enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12650591     DOI: 10.1023/a:1022446720849

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  33 in total

1.  Isn't combinatorial chemistry just chemistry?

Authors: 
Journal:  Drug Discov Today       Date:  2000-08       Impact factor: 7.851

2.  Unraveling principles of lead discovery: from unfrustrated energy landscapes to novel molecular anchors.

Authors:  P A Rejto; G M Verkhivker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

3.  The additivity of substrate fragments in enzyme-ligand binding.

Authors:  T J Stout; C R Sage; R M Stroud
Journal:  Structure       Date:  1998-07-15       Impact factor: 5.006

4.  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.

Authors:  P J Hajduk; J Dinges; G F Miknis; M Merlock; T Middleton; D J Kempf; D A Egan; K A Walter; T S Robins; S B Shuker; T F Holzman; S W Fesik
Journal:  J Med Chem       Date:  1997-09-26       Impact factor: 7.446

5.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

6.  A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.

Authors:  J Rao; J Lahiri; L Isaacs; R M Weis; G M Whitesides
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

7.  Entropy in biological binding processes: estimation of translational entropy loss.

Authors:  K P Murphy; D Xie; K S Thompson; L M Amzel; E Freire
Journal:  Proteins       Date:  1994-01

8.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

9.  Identification of novel inhibitors of urokinase via NMR-based screening.

Authors:  P J Hajduk; S Boyd; D Nettesheim; V Nienaber; J Severin; R Smith; D Davidson; T Rockway; S W Fesik
Journal:  J Med Chem       Date:  2000-10-19       Impact factor: 7.446

10.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

Authors:  Y A Puius; Y Zhao; M Sullivan; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

View more
  42 in total

Review 1.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go.

Authors:  N Moitessier; P Englebienne; D Lee; J Lawandi; C R Corbeil
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

3.  How sophisticated should a scoring function be to ensure successful docking, scoring and virtual screening?

Authors:  Dmitry Tarasov; Dmitry Tovbin
Journal:  J Mol Model       Date:  2008-12-09       Impact factor: 1.810

4.  CONFIRM: connecting fragments found in receptor molecules.

Authors:  David C Thompson; R Aldrin Denny; Ramaswamy Nilakantan; Christine Humblet; Diane Joseph-McCarthy; Eric Feyfant
Journal:  J Comput Aided Mol Des       Date:  2008-07-09       Impact factor: 3.686

5.  Multivalency in the assembly of intrinsically disordered Dynein intermediate chain.

Authors:  Justin Hall; P Andrew Karplus; Elisar Barbar
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

Review 6.  The rise of fragment-based drug discovery.

Authors:  Christopher W Murray; David C Rees
Journal:  Nat Chem       Date:  2009-06       Impact factor: 24.427

Review 7.  Applying thermodynamic profiling in lead finding and optimization.

Authors:  Gerhard Klebe
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

8.  The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).

Authors:  Lakshmi Ganesan; Peter Buchwald
Journal:  J Mol Recognit       Date:  2013-04       Impact factor: 2.137

Review 9.  Fragment-based approaches to enzyme inhibition.

Authors:  Alessio Ciulli; Chris Abell
Journal:  Curr Opin Biotechnol       Date:  2007-10-24       Impact factor: 9.740

10.  Toward accurate microscopic calculation of solvation entropies: extending the restraint release approach to studies of solvation effects.

Authors:  Nidhi Singh; Arieh Warshel
Journal:  J Phys Chem B       Date:  2009-05-21       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.